296 related articles for article (PubMed ID: 1346646)
1. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
[TBL] [Abstract][Full Text] [Related]
2. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
Cass WA
J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
[TBL] [Abstract][Full Text] [Related]
3. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Smith MP; Peters LE
Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
Albers DS; Sonsalla PK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
[TBL] [Abstract][Full Text] [Related]
5. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
[TBL] [Abstract][Full Text] [Related]
6. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
7. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
8. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
9. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
Broening HW; Morford LL; Vorhees CV
Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine treatment affects blood and liver S-adenosylmethionine (SAM) in mice. Correlation with dopamine depletion in the striatum.
Cooney CA; Wise CK; Poirier LA; Ali SF
Ann N Y Acad Sci; 1998 May; 844():191-200. PubMed ID: 9668677
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
Bowyer JF; Robinson B; Ali S; Schmued LC
Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184
[TBL] [Abstract][Full Text] [Related]
13. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
14. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced spectrin proteolysis in the rat striatum.
Staszewski RD; Yamamoto BK
J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
[TBL] [Abstract][Full Text] [Related]
16. Fluoro-gold and pentamidine inhibit the in vitro and in vivo release of dopamine in the striatum of rat.
Bowyer JF; Gough B; Broening HW; Newport GD; Schmued L
J Pharmacol Exp Ther; 1993 Aug; 266(2):1066-74. PubMed ID: 8355181
[TBL] [Abstract][Full Text] [Related]
17. Effects of postnatal exposure to methamphetamine on the development of the rat retina.
Rodrigues LG; Melo P; Silva MC; Tavares MA
Ann N Y Acad Sci; 2006 Aug; 1074():604-19. PubMed ID: 17105956
[TBL] [Abstract][Full Text] [Related]
18. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
Themann C; Alvarez Fischer D; Gross S; Westermann R; Weihe E; Kuschinsky K; Schäfer H; Ferger B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):22-8. PubMed ID: 11862330
[TBL] [Abstract][Full Text] [Related]
19. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
Gough B; Pereira FC; Fontes Ribeiro CA; Ali SF; Binienda ZK
Neurochem Int; 2014 Oct; 76():109-13. PubMed ID: 25049173
[TBL] [Abstract][Full Text] [Related]
20. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
Kitamura O
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]